Consultation: Exceptions to the Prescription Drug List

From: Health Canada

Current status: Open

Opened on July 28, 2022 and will close to new input on November 29, 2022.

We're seeking input from health care providers and other stakeholders on current exceptions to the Prescription Drug List as part of regulatory modernization. We'll use the information gathered from this consultation to inform updated health and safety rationales for exceptions to the Prescription Drug List.

Join in: how to participate

We invite you to read the consultation guide and then provide your feedback by:

  1. Completing the online questionnaire
  2. Emailing us a written submission

Consult the product list as needed as you respond to the questionnaire and provide your input.

Complete the questionnaire

Who is the focus of this consultation

Health Canada will seek feedback from:

Key questions

To seek your feedback on whether some exceptions to the Prescription Drug List are still required and why, we've prepared:

We also want to know what impacts could result if these drugs were to be added to the Prescription Drug List.

Learn more about:

Related links

Contact us

Exceptions to the Prescription Drug List
Health Products and Food Branch
policy_bureau_enquiries@hc-sc.gc.ca

Report a problem or mistake on this page
Please select all that apply:

Thank you for your help!

You will not receive a reply. For enquiries, contact us.

Date modified: